ONE Bio First Company With China Operations to Make State Administration of Taxation Filings Public to Investors
01 Junho 2011 - 9:00AM
Marketwired
ONE Bio, Corp. ("ONE" or the "Company") (OTCBB: ONBI), an
innovative company utilizing green process manufacturing to produce
raw chemicals and herbal extracts, natural and health supplements
and organic products, today announced it has made its State
Administration of Taxation ("SAT") filings available to investors.
The SAT is a ministerial-level department within the government
of the People's Republic of China that is responsible for the
collection of taxes. ONE's operating subsidiaries in China, Sanming
Huajian Bioengineering Co., Ltd., Jian'ou Lujian Foodstuff Co.,
Ltd., Fuijian Green Planet Bio-engineering Co., Ltd., and Fuijian
Green United Bamboo Technology Co., Ltd., each report individually
to the SAT. Various differences between Chinese GAAP, as required
by the SAT, and U.S. GAAP, as required by the SEC, require
reconciliation of the filings for comparison purposes. Tax filings
made with the SAT are based on audited financial data.
The Company's SAT filings, including corresponding U.S. GAAP
reconciliation documents prepared by the Company and reviewed by
its accounting firm, through 2009, are available at the following
link:
http://redchip.com/visibility/investor.asp?symbol=ONBI
The Company also intends to make its 2010 SAT filings public in
the near future.
Marius Silvasan, ONE's CEO, stated, "We understand the market's
concern over the veracity of filings for companies with operations
in China. We are pleased to address these concerns by making our
historical SAT filings, which are materially in line with our SEC
filings, available for the investment community to review. We have
also included reconciliation information for the first nine months
of 2010 and will make available our 2010 SAT filings as soon as
they are completed in the coming weeks."
About ONE Bio, Corp. ONE Bio, Corp.
("ONE") (OTCBB: ONBI) (www.onehcorp.com), headquartered in Miami,
FL, is an innovative company utilizing patented green process
manufacturing to produce raw chemicals and herbal extracts, natural
supplements and organic products. ONE is focused on the Asia
Pacific region and the United States. Key products include widely
recognized Solanesol, CoQ10, Resveratrol and 5-HTP, organic
fertilizers, and organic bamboo health food and beverages. ONE has
experienced solid organic growth driven by a robust demand for its
products in China, Japan and the United States.
This press release includes statements that constitute
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995 (the "Reform Act"). ONE
Bio, Corp. claims the protection of the safe-harbor for
forward-looking statements contained in the Reform Act. These
forward-looking statements are often characterized by the terms
"may," "believes," "projects," "expects," or "anticipates," and do
not reflect historical facts. Specific forward-looking statements
contained in this press release include, but are not limited to:
our successful integration of diversified growth companies, impact
of the company's expansion plan, and new business development
success, future financial results, development and acquisition of
new product lines and services, the impact of competitive products
or pricing from technological changes, the effect of economic
conditions and other uncertainties. The forward-looking statements
contained herein involve risks and uncertainties that could cause
actual results to differ materially from the expectations contained
in any such forward-looking statements. These risks include, but
are not limited to: failure to manage operating expenses or
integrate new companies and/or technologies, each of which could
have a material impact on our business, our financial results, and
the company's stock price. These risks and other factors are
detailed in the Company's regular filings with the U.S. Securities
and Exchange Commission. Most of these factors are difficult to
predict accurately and are generally beyond the Company's control.
Forward-looking statements speak only as to the date they are made
and ONE Bio, Corp. does not undertake to update forward-looking
statements to reflect circumstances or events that occur after the
date the forward-looking statements are made.
Company Contact: Marius Silvasan CEO Tel. + 786-288-3488 Email:
msilvasan@onehcorp.com Investor Relations Contact: Chris Schilling
RedChip Companies, Inc. Tel: +1-800-733-2447, Ext. 131 Email:
info@redchip.com
One Bio (CE) (USOTC:ONBI)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
One Bio (CE) (USOTC:ONBI)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024